[1]
R. J. Barohn, “Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy”, rrnmf, vol. 3, no. 2, pp. 45–98, Jun. 2022, doi: 10.17161/rrnmf.v3i2.18133.